India · Delayed Price · Currency is INR Kopran Company Description
Kopran Limited, an integrated pharmaceutical company, engages in the development, manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally.
The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations.
It also provides drugs in the categories of macrolide, penicillin, quinolone, anti-protozoal, sulphonamides, respiratory, tetracycline, cardiovascular, anti-diabetic, urology, pain management and anti-inflammatory, gastrointestinal, erectile dysfunction, anthemintic, anti-allergic, central nervous system, anti-malarial, anti-thyroid, and carbapenems.
In addition, the company offers drugs for anti-hypertensive, neuromodulator, anti-acne, anti-infective, antibiotic, anti-thrombotic, anti-diabetic, anti-asthamatic, antihyperlipidemic, anti-convulsants, anti-anxiety, pulmonary arterial hypertension, chronic heart failure, neuropathic pain, and erosive esophagitis.
Kopran Limited was incorporated in 1958 and is based in Mumbai, India.
| Country | India |
| Founded | 1958 |
| Industry | Drug Manufacturers - General |
| Sector | Healthcare |
| Employees | 1,156 |
| CEO | Surendra Somani |
Contact Details
Address: Parijat House Mumbai, 400018 India | |
| Phone | 91 22 4366 1111 |
| Website | kopran.com |
Stock Details
| Ticker Symbol | KOPRAN |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| ISIN Number | INE082A01010 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Surendra Shrikrishna Somani B.Com. | Chairman and MD |
| Basant Kumar Soni | Chief Financial Officer |
| Sunil Radheyshyam Sodhani | Company Secretary and Compliance Officer |
| Ajit Jain FCA | Chief Operating Officer |
| Vijay L Thange | Chief Technical Officer |
| Deepika Merita | Company Secretary |